The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Filip Lindkvist - Redeye AB - Analyst
: Yes, hi, and thanks for taking our questions. I see that the time is moving fast, but a couple of ones from my end. So if we start with the US
health giant, do you still anticipate to participate with some resources in the study?
LSEG STREETEVENTS | www.lseg.com | Contact Us
consent of LSEG. 'LSEG' and the LSEG logo are registered trademarks of LSEG and its affiliated companies.
DECEMBER 18, 2025 / 2:00PM, BIOVICb.ST - Q2 2026 Biovica International AB Earnings Call
Question: Filip Lindkvist - Redeye AB - Analyst
: Understood.
Question: Filip Lindkvist - Redeye AB - Analyst
: And what do you expect when it comes to revenue recognition? Is it front heavy, back heavy, or evenly distributed?
Question: Filip Lindkvist - Redeye AB - Analyst
: Yes.
Question: Filip Lindkvist - Redeye AB - Analyst
: Okay. And if we move over to Tempus, the timing has slipped to H2 2026 to develop a joint value proposition, and this ambition from
Tempus is positive as it shows commitment from their side. And in the Q1 call, you mentioned the possibility of an early launch of a standalone
dividend product to reduce complexity. Is it this still an option or do we still go for a deeper integration?
Question: Filip Lindkvist - Redeye AB - Analyst
: Okay. Fair. And...
Question: Filip Lindkvist - Redeye AB - Analyst
: And despite removing your financial targets, you still have an ambition of achieving positive cash flow in 2027. Can you elaborate on this
in light of the delayed partnerships and your expectations on OpEx going forward?
Question: Filip Lindkvist - Redeye AB - Analyst
: And the last question for me, as you mentioned, pharma services seems to progress well. But if we exclude pharmer services for now, what
are your expectations on the organic growth without the partnerships in the US going forward?
Question: Filip Lindkvist - Redeye AB - Analyst
: Got it. That's all left for me. Thank you.
| 
